Pharmacotherapy of primary CNS lymphoma. - Wikidata - awgldk - TriplyDB

Pharmacotherapy of primary CNS lymphoma.

Pharmacotherapy of primary CNS lymphoma.

http://www.wikidata.org/entity/Q34482032

about

Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.

P2860

Q36492327-42CC7065-2EFB-49A2-92C9-83D9EB5FE05F

P2860

Pharmacotherapy of primary CNS lymphoma.

http://www.wikidata.org/entity/Q34482032

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Pharmacotherapy of primary CNS lymphoma.

@ast

Pharmacotherapy of primary CNS lymphoma.

@en

Pharmacotherapy of primary CNS lymphoma.

@nl

type

label

Pharmacotherapy of primary CNS lymphoma.

@ast

Pharmacotherapy of primary CNS lymphoma.

@en

Pharmacotherapy of primary CNS lymphoma.

@nl

prefLabel

Pharmacotherapy of primary CNS lymphoma.

@ast

Pharmacotherapy of primary CNS lymphoma.

@en

Pharmacotherapy of primary CNS lymphoma.

@nl

P1433

Q34482032-6B2C63D8-6F9C-4BDB-BC20-2DB6DF310833

P1476

Q34482032-46A30F9D-002F-4C4A-AABC-4A0D885AAC27

P2093

Q34482032-3220B986-9501-43DB-B04C-FB9E84B583AD

Q34482032-3789A06B-1076-4218-8EEA-9351C834FE3B

P2860

Q34482032-03D98F8D-48B7-4A9C-BF60-18C5C59D8E4D

Q34482032-106CBA55-2DBC-42FE-80AD-810C5541EEA2

Q34482032-424E454C-793F-4D33-9325-1C91846B9F26

Q34482032-4E71D967-4FD8-4133-98A7-A3AAB2282957

Q34482032-55916DA9-5718-439C-8306-511F6E4FBE83

Q34482032-55CC7D73-8347-4164-AB72-D5D8F65B1264

Q34482032-73762B3D-D384-42A6-8D7C-76398ACAEA28

Q34482032-738B341E-3ACE-47E0-9DDF-77393257ED1F

Q34482032-79F6A096-E9E7-4BCA-A74D-6162C1A9E0F5

Q34482032-A5BC168D-EBE2-4D8C-8AAC-2E6E9803347B

P304

Q34482032-86FB6F31-C4B3-44D2-826E-7DDD951F6EC6

P31

Q34482032-456449A3-196C-4848-9BE6-C5D2F9519A86

P356

Q34482032-AC0B345A-8349-4F4F-B87B-93A3CBF16BA6

P407

Q34482032-A16809E5-23D8-4BCD-BBB1-8E6FE7C995B0

P433

Q34482032-2B84993B-877E-4A8F-A39D-83386AD68286

P478

Q34482032-E7CB1328-7394-469A-A9F7-37BB67E0BDE0

P577

Q34482032-D89C934F-69C1-4DA4-BA0F-3233E307534F

P698

Q34482032-E2C97667-F1C6-4DD3-BEE4-00D742C56072

P921

Q34482032-023D32EA-5A1E-4EC5-A481-EAA85667015F

P356

14656566.3.1.39

P1433

Expert Opinion on Pharmacotherapy

P1476

Pharmacotherapy of primary CNS lymphoma.

@en

P2093

Deric Minwoo Park

http://www.w3.org/2001/XMLSchema#string

Lauren E Abrey

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing incidence of primary brain lymphoma in the US

Vincristine revisited

Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.

Glucocorticoid treatment of primary CNS lymphoma.

A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma.

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.

Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature.

Transient cerebral dysfunction secondary to high-dose methotrexate.

Quantification and pharmacokinetics of blood-brain barrier disruption in humans.

Intrathecal N, N', N"-triethylenethiophosphoramide [thio-TEPA (NSC 6396)] in the treatment of malignant meningeal disease: phase I-II study.

P304

39-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.3.1.39

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11772332

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy